Cytogenetic analysis may predict nonresponse of gastric MALT lymphoma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1270, 2001-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infliximab: Gastric MALT lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1208, 2008-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Treatment of gastric marginal zone lymphoma of MALT type

By Stathis Anastasios Bertoni Francesco Zucca Emanuele

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2141-2152

Informa Healthcare

Access to resources Recommend Favorite

New Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1097-1103

Bentham Science Publishers

Access to resources Recommend Favorite

Rituximab shows activity in MALT lymphoma

Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Detection rate of fluorine‐18‐fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta‐analysis

Hematological Oncology (Electronic), Vol. 278-0232, Iss. 3, 2015-09 ,pp. : 113-124

John Wiley & Sons Inc

Access to resources Recommend Favorite